We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Bath & Body Works
BBWI
$3.37B
| – | – |
-6,671
| Closed | -$307K |
|
1077
Best Buy
BBY
$19.4B
| – | – |
-9,272
| Closed | -$250K |
|
1078
Brunswick
BC
$4.39B
| – | – |
-4,639
| Closed | -$211K |
|
1079
Belden
BDC
$4.4B
| – | – |
-43,345
| Closed | -$3.02M |
|
1080
Brown-Forman Class B
BF.B
$11.8B
| – | – |
-172,684
| Closed | -$4.96M |
|
1081
Bunge Global
BG
$22.5B
| – | – |
-10,729
| Closed | -$854K |
|
|
BNY
1082
Bank of New York Mellon
BNY
$104B
| – | – |
-44,852
| Closed | -$1.58M |
|
1083
Popular Inc
BPOP
$10.3B
| – | – |
-8,370
| Closed | -$260K |
|
1084
Bruker
BRKR
$9.24B
| – | – |
-236,077
| Closed | -$5.38M |
|
1085
Boyd Gaming
BYD
$5.49B
| – | – |
-20,820
| Closed | -$275K |
|
|
CADE
1086
DELISTED
Cadence Bank
CADE
| – | – |
-10,932
| Closed | -$273K |
|
1087
PUT
Avis
CAR
$4.13B
| – | – |
-18,200
| Closed | -$888K |
|
1088
CDW
CDW
$18.7B
| – | – |
-31,591
| Closed | -$868K |
|
1089
Cognex
CGNX
$10.1B
| – | – |
-16,480
| Closed | -$280K |
|
1090
C.H. Robinson
CHRW
$17.9B
| – | – |
-5,607
| Closed | -$294K |
|
1091
Core Laboratories
CLB
$525M
| – | – |
-3,200
| Closed | -$636K |
|
1092
PUT
Comcast
CMCSA
$84.2B
| – | – |
-191,400
| Closed | -$4.79M |
|
1093
Canadian National Railway
CNI
$72.3B
| – | – |
-11,800
| Closed | -$664K |
|
1094
ConocoPhillips
COP
$159B
| – | – |
-177,341
| Closed | -$12.5M |
|
1095
Cencora
COR
$60.8B
| – | – |
-7,764
| Closed | -$510K |
|
1096
Carpenter Technology
CRS
$20.4B
| – | – |
-15,300
| Closed | -$1.01M |
|
1097
Criteo S.A.
CRTO
$838M
| – | – |
-22,565
| Closed | -$916K |
|
1098
Cisco
CSCO
$425B
| – | – |
-20,814
| Closed | -$467K |
|
1099
CSX Corp
CSX
$88.7B
| – | – |
-46,761
| Closed | -$452K |
|
1100
CALL
Cytokinetics
CYTK
$9.65B
| – | – |
-400,000
| Closed | -$3.8M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.